Cargando…
B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome
Antibody-mediated rejection (ABMR) of renal allograft lacks typical phenotypes and clinical manifestations, always resulting in delayed diagnosis and treatment. It has been considered to be an elemental factor influencing the improvement of the long-term outcome of renal allograft. The B cell activa...
Autores principales: | Xu, Haiyan, He, Xiaozhou, Xu, Renfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011068/ https://www.ncbi.nlm.nih.gov/pubmed/29977928 http://dx.doi.org/10.1155/2018/5251801 |
Ejemplares similares
-
Early Eosinophilic Antibody-mediated Rejection in a Renal Allograft Recipient
por: Satish, H., et al.
Publicado: (2018) -
Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step
por: Lachmann, Nils, et al.
Publicado: (2017) -
Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody
por: Suneja, Manish, et al.
Publicado: (2012) -
Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection
por: Shi, Jian, et al.
Publicado: (2015) -
THE ROLE OF HUMORAL ANTIBODY IN THE REJECTION OF PRIMARY RENAL ALLOGRAFTS IN SHEEP
por: Pedersen, Niels C., et al.
Publicado: (1974)